Bills

SB 1509: RELATING TO PRESCRIPTION DRUGS.

  • Session Year: 2025-2026
  • House: Senate

Current Status:

In Progress

(2025-03-19: The committee(s) on CPC recommend(s) that the measure be deferred.)

Introduced

First Committee Review

First Chamber

Second Committee Review

Second Chamber

Final Decking

Enacted

Version:

Requires health insurers and pharmacy benefit managers to reduce an enrollee's defined cost sharing for a prescription drug by a price amount equal to at least 100 per cent of all rebates received, or to be received, in connection with the dispensing or administration of the prescription drug.  Requires a pharmacy benefit manager to submit a certification to the Insurance Commissioner by January 1 of each calendar year certifying compliance with the cost sharing requirements.  Establishes protections for the publishing of certain confidential or proprietary information by health insurers or pharmacy benefit managers. 

Discussed in Hearing

House Standing Committee on Consumer Protection & Commerce3MIN
Mar 19, 2025

House Standing Committee on Consumer Protection & Commerce

House Standing Committee on Health27MIN
Mar 12, 2025

House Standing Committee on Health

Senate Standing Committee on Commerce and Consumer Protection9MIN
Feb 24, 2025

Senate Standing Committee on Commerce and Consumer Protection

Senate Standing Committee on Health and Human Services9MIN
Feb 24, 2025

Senate Standing Committee on Health and Human Services

View Older Hearings

News Coverage:

SB 1509: RELATING TO PRESCRIPTION DRUGS. | Digital Democracy